Shafer Christina
Insider CIK 1934412 · MRNS Chief Commercial Officer · NGNE Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NGNE Neurogene Inc. | A Award deriv | 2026-05-05 | 2026-05-07 | 120,000 | — | $0 | 120,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 49,125 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 128,000 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 15,000 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 57,900 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 98,250 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 78,188 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer | 2025-02-11 | 2025-02-11 | 48,628 | $0.55 | $26.7K | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer | 2025-02-07 | 2025-02-11 | 18,778 | $0.55 | $10.3K | 48,628 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2024-08-05 | 2024-08-07 | 3,820 | $1.14 | $4.4K | 67,406 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2024-06-18 | 2024-06-20 | 49,125 | — | $0 | 49,125 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2024-06-18 | 2024-06-20 | 10,918 | — | $0 | 71,226 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2024-02-20 | 2024-02-22 | 2,153 | $9.56 | $20.6K | 60,308 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2024-01-18 | 2024-01-19 | 98,250 | — | $0 | 98,250 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2024-01-18 | 2024-01-19 | 21,835 | — | $0 | 62,461 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2023-08-08 | 2023-08-08 | 11 | $8.93 | $98 | 40,626 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2023-08-07 | 2023-08-08 | 2,385 | $9.52 | $22.7K | 40,637 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2023-01-26 | 2023-01-30 | 78,188 | — | $0 | 78,188 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2023-01-26 | 2023-01-30 | 17,375 | — | $0 | 43,022 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | F Tax w/h | 2022-11-09 | 2022-11-14 | 1,505 | $4.70 | $7.1K | 25,647 | SEC↗ |